• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺泡巨噬细胞:肺泡脂质星系的守护者。

Alveolar macrophages: guardians of the alveolar lipid galaxy.

作者信息

Little Isaiah, Bersie Stephanie, Redente Elizabeth F, McCubbrey Alexandra L, Tarling Elizabeth J

机构信息

Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, California.

Toxicology Graduate Program, Skaggs School of Pharmacy and Pharmaceutical Sciences.

出版信息

Curr Opin Lipidol. 2025 Jun 1;36(3):153-162. doi: 10.1097/MOL.0000000000000987. Epub 2025 Apr 2.

DOI:10.1097/MOL.0000000000000987
PMID:40183504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12043416/
Abstract

PURPOSE OF REVIEW

As the primary guardians at the air-surface interface, the functional profile of alveolar macrophages (AM) is wide-ranging from establishment of the alveolar niche, homeostatic maintenance of surfactant levels, to pathogen clearance and resolution and repair processes. Alveolar lipid homeostasis is disturbed in chronic lung diseases and contributes to disease pathogenesis through extracellular localization in the alveolar lumen or intracellular accumulation in AM. This review aims to provide a focused overview of the state of knowledge of AM, their ontogeny and development during health and disease, and how dysregulated AM lipids play a key role in disease processes, from initiation to resolution.

RECENT FINDINGS

While lipid-laden macrophages are observed across a broad spectrum of lung diseases, their occurrence has largely been considered consequential. Recent advances in lipidomic profiling of single cell types has revealed that disturbances to lipid homeostasis occur early in disease in tissue-resident cells. Comparisons between inflammatory and fibrotic injury models reveal specific alveolar macrophage subsets with different lipid utilization that contribute to the disease process.

SUMMARY

Understanding the intricate web of AM population seeding and development and how this niche is perturbed by lipid disturbances may help provide leverage for new interventions.

摘要

综述目的

作为气-液界面的主要守护者,肺泡巨噬细胞(AM)的功能广泛,涵盖肺泡微环境的建立、表面活性剂水平的稳态维持、病原体清除以及炎症消退和修复过程。慢性肺部疾病中肺泡脂质稳态受到干扰,并通过在肺泡腔内的细胞外定位或在AM中的细胞内积累促进疾病发病机制。本综述旨在重点概述AM的知识现状、它们在健康和疾病状态下的个体发生和发育,以及失调的AM脂质如何在从疾病起始到消退的过程中在疾病进程中发挥关键作用。

最新发现

虽然在广泛的肺部疾病中都观察到了脂质负载的巨噬细胞,但它们的出现大多被认为是继发性的。单细胞类型脂质组学分析的最新进展表明,脂质稳态的干扰在疾病早期就发生在组织驻留细胞中。炎症和纤维化损伤模型之间的比较揭示了具有不同脂质利用情况的特定肺泡巨噬细胞亚群,这些亚群促成了疾病进程。

总结

了解AM群体播种和发育的复杂网络,以及这个微环境如何受到脂质干扰的影响,可能有助于为新的干预措施提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa9/12052054/43c108532d9f/colip-36-153-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa9/12052054/2347cbf7d602/colip-36-153-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa9/12052054/ecb4ed84f355/colip-36-153-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa9/12052054/43c108532d9f/colip-36-153-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa9/12052054/2347cbf7d602/colip-36-153-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa9/12052054/ecb4ed84f355/colip-36-153-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fa9/12052054/43c108532d9f/colip-36-153-g003.jpg

相似文献

1
Alveolar macrophages: guardians of the alveolar lipid galaxy.肺泡巨噬细胞:肺泡脂质星系的守护者。
Curr Opin Lipidol. 2025 Jun 1;36(3):153-162. doi: 10.1097/MOL.0000000000000987. Epub 2025 Apr 2.
2
Alveolar lipids in pulmonary disease. A review.肺部疾病中的肺泡脂质。综述。
Lipids Health Dis. 2020 Jun 3;19(1):122. doi: 10.1186/s12944-020-01278-8.
3
Air Space Distension Precedes Spontaneous Fibrotic Remodeling and Impaired Cholesterol Metabolism in the Absence of Surfactant Protein C.在缺乏表面活性蛋白 C 的情况下,空气空间扩张先于自发性纤维化重塑和胆固醇代谢受损。
Am J Respir Cell Mol Biol. 2020 Apr;62(4):466-478. doi: 10.1165/rcmb.2019-0358OC.
4
Lung surfactant metabolism: early in life, early in disease and target in cell therapy.肺表面活性物质代谢:生命早期、疾病早期及细胞治疗靶点
Cell Tissue Res. 2017 Mar;367(3):721-735. doi: 10.1007/s00441-016-2520-9. Epub 2016 Oct 25.
5
A pneumocyte-macrophage paracrine lipid axis drives the lung toward fibrosis.肺上皮细胞-巨噬细胞旁分泌脂质轴促使肺部走向纤维化。
Am J Respir Cell Mol Biol. 2015 Jul;53(1):74-86. doi: 10.1165/rcmb.2014-0343OC.
6
Pharmacological activation of liver X receptor during cigarette smoke exposure adversely affects alveolar macrophages and pulmonary surfactant homeostasis.在香烟烟雾暴露期间,肝 X 受体的药理学激活会对肺泡巨噬细胞和肺表面活性剂的动态平衡产生不利影响。
Am J Physiol Lung Cell Mol Physiol. 2019 Apr 1;316(4):L669-L678. doi: 10.1152/ajplung.00482.2018. Epub 2019 Jan 31.
7
Temsirolimus induces surfactant lipid accumulation and lung inflammation in mice.替西罗莫司可诱导小鼠肺表面活性剂脂质蓄积和肺部炎症。
Am J Physiol Lung Cell Mol Physiol. 2014 Jun 15;306(12):L1117-28. doi: 10.1152/ajplung.00251.2013. Epub 2014 May 2.
8
Etiology of lipid-laden macrophages in the lung.肺内富含脂质的巨噬细胞的病因。
Int Immunopharmacol. 2023 Oct;123:110719. doi: 10.1016/j.intimp.2023.110719. Epub 2023 Aug 16.
9
Hepatic Steatosis Accompanies Pulmonary Alveolar Proteinosis.肝脂肪变性伴发肺泡蛋白沉积症。
Am J Respir Cell Mol Biol. 2017 Oct;57(4):448-458. doi: 10.1165/rcmb.2016-0242OC.
10
CD44 Loss Disrupts Lung Lipid Surfactant Homeostasis and Exacerbates Oxidized Lipid-Induced Lung Inflammation.CD44 缺失破坏肺脂质表面活性剂稳态并加剧氧化脂质诱导的肺部炎症。
Front Immunol. 2020 Jan 30;11:29. doi: 10.3389/fimmu.2020.00029. eCollection 2020.

本文引用的文献

1
Gpnmb and Spp1 mark a conserved macrophage injury response masking fibrosis-specific programming in the lung.Gpnmb和Spp1标志着一种保守的巨噬细胞损伤反应,掩盖了肺中纤维化特异性编程。
JCI Insight. 2024 Dec 20;9(24):e182700. doi: 10.1172/jci.insight.182700.
2
Profibrotic monocyte-derived alveolar macrophages are expanded in patients with persistent respiratory symptoms and radiographic abnormalities after COVID-19.COVID-19 后持续存在呼吸道症状和影像学异常的患者中,纤维生成性单核细胞衍生的肺泡巨噬细胞增多。
Nat Immunol. 2024 Nov;25(11):2097-2109. doi: 10.1038/s41590-024-01975-x. Epub 2024 Oct 4.
3
Endogenous LXR signaling controls pulmonary surfactant homeostasis and prevents lung inflammation.
内源性 LXR 信号通路控制肺表面活性剂的动态平衡,防止肺部炎症。
Cell Mol Life Sci. 2024 Jul 6;81(1):287. doi: 10.1007/s00018-024-05310-3.
4
Lipid-Laden Macrophages in Pulmonary Diseases.肺部疾病中的富含脂质的巨噬细胞。
Cells. 2024 May 22;13(11):889. doi: 10.3390/cells13110889.
5
The role of lysosomal phospholipase A2 in the catabolism of bis(monoacylglycerol)phosphate and association with phospholipidosis.溶酶体磷脂酶 A2 在双(单酰基甘油)磷酸酯分解代谢中的作用及其与磷脂蓄积的关系。
J Lipid Res. 2024 Jul;65(7):100574. doi: 10.1016/j.jlr.2024.100574. Epub 2024 Jun 9.
6
Reexamining the Role of Pulmonary Lipids in the Pathogenesis of Pulmonary Fibrosis.重新审视肺脂质在肺纤维化发病机制中的作用。
Am J Respir Cell Mol Biol. 2024 Oct;71(4):407-419. doi: 10.1165/rcmb.2024-0124PS.
7
Aberrant Lipid Metabolism in Macrophages Is Associated with Granuloma Formation in Sarcoidosis.巨噬细胞中的脂质代谢异常与肉样瘤病中的肉芽肿形成有关。
Am J Respir Crit Care Med. 2024 May 1;209(9):1152-1164. doi: 10.1164/rccm.202307-1273OC.
8
EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth.表皮生长因子受体驱动的肺腺癌利用肺泡巨噬细胞的代谢和功能来支持表皮生长因子受体信号传导和生长。
Cancer Discov. 2024 Jan 25:OF1-OF22. doi: 10.1158/2159-8290.CD-23-0434.
9
Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease.血管炎症和动脉粥样硬化性心血管疾病中的特异性促解决介质。
Nat Rev Cardiol. 2024 Nov;21(11):808-823. doi: 10.1038/s41569-023-00984-x. Epub 2024 Jan 12.
10
Alveolar macrophage lipid burden correlates with clinical improvement in patients with pulmonary alveolar proteinosis.肺泡巨噬细胞脂质负荷与肺泡蛋白沉积症患者的临床改善相关。
J Lipid Res. 2024 Feb;65(2):100496. doi: 10.1016/j.jlr.2024.100496. Epub 2024 Jan 6.